How can dendrimers be designed to hold and release therapeutic drugs?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Gold and palladium alloy nanoparticles — nanoparticle Image showing nanoparticles of an alloy of gold (yellow) and palladium (blue) on an acid-treated carbon support (gray). These particles were employed as catalysts for the formation of hydrogen peroxide from hydrogen (white) and oxygen (red).

Dendrimers are specialized, spherical polymeric molecules characterized by a hollow central region that functions as a carrier for therapeutic agents. Their design allows researchers to precisely tailor both their chemical properties and the size of their internal cavities to accommodate specific drugs.1

To facilitate the release of these therapeutic substances, scientists are developing dendrimers that can respond to their environment. By designing these structures to swell upon exposure to specific molecules—which serve as indicators of a disease target—the dendrimers can release their cargo at the precise location where treatment is required. This targeted approach is part of a broader effort in nanotechnology to improve the efficacy of drug therapies by ensuring that medicine is delivered on a predetermined schedule or triggered by specific biological conditions, thereby minimizing impact on healthy tissue.1